Broad Genomic Testing Tied to Longer Survival in NSCLC

1 source1 article First seen 5 hours ago Updated 5 hours ago United States Truth score 38

Save Like Comments Compare coverage

Summary

A study examines whether broad-based genomic sequencing before treatment improves survival in advanced non-small cell lung cancer compared with focused biomarker testing.

Description from Medscape.

Who is covering this

Medscape Center Factuality: Mostly factual US 5 hours ago
Broad Genomic Testing Tied to Longer Survival in NSCLC
A study examines whether broad-based genomic sequencing before treatment improves survival in advanced non-small cell lung cancer compared with focused biomarker testing.

Comments

Comments need JavaScript.

Truth score

38/100Weakly supported

Independent outlets: 1
Source reliability: 65/100
Sides of the spectrum covering it: 1/3
Propaganda risk: 0/100

How well the story is corroborated by independent, reliable outlets across the spectrum. Not a fact-check of each claim. How the truth score works

Coverage by lean

Centre 100%100%

Left: 0
Centre: 1
Right: 0
Not rated: 0

How lean is counted

Source quality

Average reliability: 65/100 (Mostly factual)
Low-credibility outlets: 0%
State media: 0%
Opinion pieces: 0%

Where ratings come from

Where the coverage comes from

United States1

Filter the stories

Sources Ratings and details

Broad Genomic Testing Tied to Longer Survival in NSCLC

Summary

Who is covering this

Comments